MAPT and tauopathy: The strong evidence that connects tau pathology and GVBs is challenged by studies reporting the presence of GVBs [17, 19–23] and putative GVBs for which CK1δ positivity was not demonstrated [3, 13–15, 24, 25] in neurons lacking signal for pathological tau markers (tau−) in the human tauopathy brain.